Epigenomics AG (FRA:ECX)
Germany
· Delayed Price · Currency is EUR 0.8900
+0.0100 (1.14%)
At close: Aug 12, 2025, 10:00 PM CET
Epigenomics AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.76 | 0.93 | 2.1 | 7.8 | 23.05 | 3.57 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 0.96 | Upgrade
|
| Cash & Short-Term Investments | 0.76 | 0.93 | 2.1 | 7.8 | 23.05 | 4.53 | Upgrade
|
| Cash Growth | -36.70% | -55.94% | -73.04% | -66.14% | 409.14% | -58.98% | Upgrade
|
| Accounts Receivable | - | - | 0.3 | 0.05 | 0.07 | 0.25 | Upgrade
|
| Other Receivables | - | - | - | - | 0.13 | 0.22 | Upgrade
|
| Receivables | - | - | 0.3 | 0.05 | 0.2 | 0.47 | Upgrade
|
| Inventory | - | - | - | 0.04 | 0.18 | 0.12 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.22 | 0.31 | Upgrade
|
| Other Current Assets | 0.03 | 0.04 | 0.08 | 0.23 | 0.06 | 0.03 | Upgrade
|
| Total Current Assets | 0.79 | 0.97 | 2.49 | 8.12 | 23.71 | 5.47 | Upgrade
|
| Property, Plant & Equipment | - | - | 0 | 0.57 | 0.89 | 1.18 | Upgrade
|
| Long-Term Investments | - | - | 2.28 | 0.79 | - | - | Upgrade
|
| Other Intangible Assets | - | - | 0.01 | 0.03 | 0.01 | 0.05 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.05 | 0.09 | Upgrade
|
| Other Long-Term Assets | 11.07 | 10.88 | 8.07 | 4.48 | - | - | Upgrade
|
| Total Assets | 11.86 | 11.85 | 12.85 | 13.99 | 24.66 | 6.8 | Upgrade
|
| Accounts Payable | - | 0.01 | 0.26 | 0.53 | 0.5 | 0.63 | Upgrade
|
| Accrued Expenses | - | 0.27 | 0.33 | 0.05 | 1.25 | 1.2 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.46 | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.09 | 0.22 | Upgrade
|
| Current Income Taxes Payable | 0.04 | 0.01 | 0.02 | 0.06 | 0.06 | 0.03 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.07 | 0.08 | Upgrade
|
| Other Current Liabilities | - | 0.18 | 0.35 | - | 0.17 | 0.27 | Upgrade
|
| Total Current Liabilities | 0.04 | 0.46 | 1.41 | 0.64 | 2.14 | 2.44 | Upgrade
|
| Long-Term Debt | 11.38 | 11.38 | 11.43 | 12.66 | - | - | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.37 | 0.46 | Upgrade
|
| Other Long-Term Liabilities | 0.45 | 0.01 | 0.01 | 5.01 | 0.03 | 0.04 | Upgrade
|
| Total Liabilities | 11.86 | 11.85 | 12.84 | 18.31 | 2.54 | 2.93 | Upgrade
|
| Common Stock | 0.88 | 0.88 | 0.85 | 4.09 | 15.54 | 5.89 | Upgrade
|
| Retained Earnings | -89.01 | -88.81 | -85.46 | -84.41 | -93.16 | -90.73 | Upgrade
|
| Comprehensive Income & Other | 88.14 | 87.93 | 84.6 | 75.99 | 99.74 | 88.71 | Upgrade
|
| Shareholders' Equity | - | - | - | -4.32 | 22.12 | 3.86 | Upgrade
|
| Total Liabilities & Equity | 11.86 | 11.85 | 12.84 | 13.99 | 24.66 | 6.8 | Upgrade
|
| Total Debt | 11.38 | 11.38 | 11.89 | 12.66 | 0.46 | 0.68 | Upgrade
|
| Net Cash (Debt) | -10.62 | -10.46 | -9.79 | -4.85 | 22.59 | 3.84 | Upgrade
|
| Net Cash Growth | - | - | - | - | 487.64% | -62.02% | Upgrade
|
| Net Cash Per Share | -12.11 | -11.92 | -11.47 | -5.97 | 40.31 | 13.30 | Upgrade
|
| Filing Date Shares Outstanding | 0.88 | 0.88 | 0.85 | 0.82 | 0.78 | 0.29 | Upgrade
|
| Total Common Shares Outstanding | 0.88 | 0.88 | 0.85 | 0.82 | 0.78 | 0.29 | Upgrade
|
| Working Capital | 0.75 | 0.51 | 1.08 | 7.48 | 21.57 | 3.03 | Upgrade
|
| Book Value Per Share | - | - | - | -5.28 | 28.47 | 13.12 | Upgrade
|
| Tangible Book Value | - | - | -0.01 | -4.35 | 22.11 | 3.81 | Upgrade
|
| Tangible Book Value Per Share | - | - | -0.01 | -5.31 | 28.45 | 12.94 | Upgrade
|
| Machinery | - | - | 0.05 | 1.82 | 1.86 | 1.85 | Upgrade
|
| Leasehold Improvements | - | - | - | 0.85 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.